Shoulder · Editorial Cost Guide · 2026 Edition

Shoulder Stem Cell Therapy Cost Guide

Rotator cuff tendinopathy, partial rotator cuff tears, and glenohumeral osteoarthritis are increasingly studied indications for regenerative therapy. Evidence is mixed — strongest for partial tendon injuries, weaker for advanced OA.

Reviewed by board-certified physician advisor Sources: Cochrane Review 2025, Mayo Clinic, Johns Hopkins Pricing aggregated from 250+ US clinics

Last reviewed April 27, 2026 · No clinic recommendations · No personal data collected on this page

Shoulder stem cell therapy editorial illustration

This page is educational reference material. It does not promote, endorse, or sell stem cell therapy or any specific clinic, provider, or treatment. Stem cell therapies for shoulder conditions are not approved by the U.S. Food and Drug Administration. Discuss any treatment decision with a board-certified physician familiar with your medical history.

National price range — shoulder

Per-session cash price most commonly reported in the United States in early 2026. Insurance does not cover these procedures.

National Low

$3,000

Median Price

$5,200

National High

$7,500

Methodology: pricing aggregated from clinic-published rate sheets, anonymized patient-submitted invoices, and direct quotes received in the past 12 months. Top and bottom 5% outliers excluded.

What the published evidence shows

Cochrane Review 2025 · Mayo Clinic · Johns Hopkins

A growing literature, including small RCTs and large case series, reports symptomatic improvement in 55–70% of patients with rotator cuff tendinopathy or partial tears at 6–12 months. Outcomes in full-thickness rotator cuff tears and advanced glenohumeral OA are less encouraging in published data.

Treatment protocol & alternatives

Common protocols

Common protocols include BMAC, adipose MSC, and PRP — sometimes combined. Ultrasound-guided injection is standard. The shoulder offers multiple distinct injection targets (subacromial, intra-articular, intratendinous) and the chosen target depends on diagnosis.

Alternatives to consider

Physical therapy (the most evidence-supported first-line approach for rotator cuff tendinopathy), corticosteroid injection, arthroscopic rotator cuff repair, shoulder arthroplasty (for advanced OA).

Frequently asked questions

Evidence supports symptomatic improvement in tendinopathy and partial tears. Evidence does NOT support stem cell therapy as a substitute for surgical repair in significant full-thickness tears. Imaging diagnosis drives the decision.

Almost always under ultrasound guidance. The clinician identifies the target tissue (subacromial space, glenohumeral joint, or tendon substance) and delivers the injection accordingly.

Slightly — shoulder protocols typically run $500–$800 below knee equivalents, primarily due to lower processing volume and shorter procedure time.

What to ask your physician

1What is the published evidence for stem cell therapy in my specific shoulder condition and stage — not stem cell therapy in general?
2What cell source and processing method does this clinic use, and why for shoulder specifically?
3What is the all-in cost (procedure, imaging, follow-up, possible second session) — not the headline price?
4What outcome should I expect at 3, 6, 12, and 24 months, and how is "success" being defined?
5What are the alternatives I should consider first or in parallel? (See the alternatives panel above.)
6How is the clinic regulated and what is the physician's specific training in this procedure?

Get a personalized shoulder stem cell cost estimate

Tell us your area and we'll email you a price range and, if you'd like, a shortlist of vetted clinics. No phone pressure, no spam, you stay in control.

Thanks — check your inbox.

We'll email you a personalized cost estimate within 1 business day.

About this guide

This guide is maintained by the StemCellPrices.com editorial team. The team includes contributors with backgrounds in orthopedic medicine, regulatory affairs, health economics, and journalism. Content is reviewed by a board-certified physician advisor before publication. Pricing data is refreshed quarterly. Claims are cross-checked against PubMed, the Cochrane Database, and academic centers including Mayo Clinic and Johns Hopkins.

This guide is editorially independent — we accept no payment for inclusion or favorable mention. The optional cost-estimate form above is operated by StemCellPrices.com to match interested users with vetted clinics, and we may earn a referral fee from clinics that match a request. The referral business is fully separate from how this guide is researched and written.